These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16765874)

  • 1. Anticoagulation in atrial fibrillation: what decides? Patient status, provider opinion, or both?
    Dharmarajan TS; Lebelt AS; Norkus EP
    J Am Med Dir Assoc; 2006 Jun; 7(5):335. PubMed ID: 16765874
    [No Abstract]   [Full Text] [Related]  

  • 2. Why health care providers don't prescribe warfarin to a frail nursing home resident with atrial fibrillation.
    Cheng Hy
    J Am Med Dir Assoc; 2006 Jun; 7(5):334-5. PubMed ID: 16765873
    [No Abstract]   [Full Text] [Related]  

  • 3. National patterns of warfarin use in atrial fibrillation.
    Stafford RS; Singer DE
    Arch Intern Med; 1996 Dec 9-23; 156(22):2537-41. PubMed ID: 8951296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation.
    Dharmarajan TS; Varma S; Akkaladevi S; Lebelt AS; Norkus EP
    J Am Med Dir Assoc; 2006 Jan; 7(1):23-8. PubMed ID: 16413431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers for underuse of antihypertensive drug therapy for nursing home residents with hypertension.
    Cheng Hy
    J Am Med Dir Assoc; 2006 Jul; 7(6):405-6; author reply 406. PubMed ID: 16843245
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin prescribing in nursing homes.
    Rozzini R; Sleiman I; Trabucchi M;
    J Am Geriatr Soc; 2011 Jan; 59(1):183-4. PubMed ID: 21226702
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulation in elderly persons: a call for wider use.
    Portnoi VA
    Am Fam Physician; 1998 Jul; 58(1):39-40, 42. PubMed ID: 9672428
    [No Abstract]   [Full Text] [Related]  

  • 8. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic drug use audit in primary care--a pilot evaluation of warfarin use for patients with atrial fibrillation.
    Mortimer CL; Cottrell WN; Comino NJ
    Aust Fam Physician; 2005 Sep; 34(9):798-800. PubMed ID: 16184218
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation.
    Huang C; Siu M; Vu L; Wong S; Shin J
    J Eval Clin Pract; 2013 Oct; 19(5):938-43. PubMed ID: 22834964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: an opportunity to improve rates of warfarin utilization.
    Kim MH; Trohman RG; Christiansen S; Harsch MR; Kinser K; Reiter MJ; Pfeiffer J
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):580-3. PubMed ID: 17437588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.
    McCrory DC; Matchar DB; Samsa G; Sanders LL; Pritchett EL
    Arch Intern Med; 1995 Feb; 155(3):277-81. PubMed ID: 7832599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.
    Laguna P; Martn A; del Arco C; Gargantilla P;
    Ann Emerg Med; 2004 Jul; 44(1):3-11. PubMed ID: 15226703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for atrial fibrillation.
    Greiver M
    Can Fam Physician; 2005 Dec; 51(12):1629. PubMed ID: 16805080
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental illness and warfarin use in atrial fibrillation.
    Walker GA; Heidenreich PA; Phibbs CS; Go AS; Chiu VY; Schmitt SK; Ananth L; Frayne SM
    Am J Manag Care; 2011 Sep; 17(9):617-24. PubMed ID: 21902447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial use in nursing homes.
    Mylotte J
    J Am Geriatr Soc; 2009 May; 57(5):937-8. PubMed ID: 19470026
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of patients with non-valvular atrial fibrillation using dabigatran or warfarin in the US.
    Schoof N; Schnee J; Schneider G; Gawlik M; Zint K; Clemens A; Bartels DB
    Curr Med Res Opin; 2014 May; 30(5):795-804. PubMed ID: 24392958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.
    Choudhry NK; Soumerai SB; Normand SL; Ross-Degnan D; Laupacis A; Anderson GM
    Am J Med; 2006 Jul; 119(7):607-15. PubMed ID: 16828633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.